tirzepatide tachycardia and Cardiovascular Outcomes in Patients With Ventricular and Systolic Heart Failure Does Tirzepatide Increase Heart Rate?

The UKs drug regulator is also studying the potential for harmful side effects of GLP-1 receptor agonists after receiving hundreds of reports of acute and chronic pancreatitis, including 10 deaths, from patients taking the drugs for weight loss

Your medical team can adjust the medication dose to slow the rate of improvement, giving your eyes time to adapt safely

Cardiovascular considerations exist with both classes of compounds

For example, to consume around 100 mg of L-Carnitine, you would need to eat about 100180g of beef

Retatrutide is an investigational triple agonist (GLP-1, GIP, and glucagon receptors) not yet licensed by the MHRA or EMA, with Phase 2 data suggesting significant weight reduction but Phase 3 confirmation still required

Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins